niacin has been researched along with Bilateral Headache in 15 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To increase the probability of flushing, subjects were administered niacin ER at the upper limit of the approved dosage range (2,000 mg), and were precluded from using aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) during the study." | 9.12 | Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation. ( Cefali, EA; Shamp, TR; Simmons, PD; Stanek, EJ, 2006) |
| "To evaluate the efficacy and safety of extended-release niacin (niacin ER) either alone or in combination with atorvastatin for the lipid profile modification in the patients with coronary heart disease (CHD) and its equivalents." | 5.12 | [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification]. ( Duan, J; Li, XP; Tan, MY; Xu, ZM; Zhang, DQ; Zhao, SP, 2006) |
| " To increase the probability of flushing, subjects were administered niacin ER at the upper limit of the approved dosage range (2,000 mg), and were precluded from using aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) during the study." | 5.12 | Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation. ( Cefali, EA; Shamp, TR; Simmons, PD; Stanek, EJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (86.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BLOCK, MT | 1 |
| FRIEDMAN, AP | 1 |
| BRENNER, C | 1 |
| GOLDZIEHER, JW | 1 |
| POPKIN, GL | 1 |
| CUTTER, EP | 1 |
| MORGAN, ZR | 3 |
| SCHOGER, GA | 2 |
| PAWELKE, K | 1 |
| MANGUEL, M | 1 |
| RAMOS, AO | 1 |
| RYAN, RE | 1 |
| OGDEN, HD | 1 |
| CHING, CL | 1 |
| GRENFELL, RF | 1 |
| Li, XP | 1 |
| Duan, J | 1 |
| Zhao, SP | 1 |
| Tan, MY | 1 |
| Xu, ZM | 1 |
| Zhang, DQ | 1 |
| Cefali, EA | 1 |
| Simmons, PD | 1 |
| Stanek, EJ | 1 |
| Shamp, TR | 1 |
2 trials available for niacin and Bilateral Headache
| Article | Year |
|---|---|
[Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coron | 2006 |
Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Body Mass Index; Cross-Over Studies; Delayed-Action P | 2006 |
13 other studies available for niacin and Bilateral Headache
| Article | Year |
|---|---|
The treatment of headache with sodium nicotinate.
Topics: Anions; Headache; Humans; Ions; Niacin; Sodium; Sodium, Dietary | 1948 |
The use of sodium nicotinate in the treatment of headache.
Topics: Acids, Noncarboxylic; Anions; Headache; Humans; Ions; Niacin; Sodium; Sodium, Dietary | 1948 |
Treatment of headache with intravenous sodium nicotinate.
Topics: Anions; Headache; Humans; Ions; Niacin; Nicotinic Acids; Sodium; Sodium, Dietary | 1946 |
The management of headache.
Topics: Cardiovascular Agents; Disease Management; Ergot Alkaloids; Headache; Migraine Disorders; Niacin; Ni | 1953 |
Nicotinic acid therapy in vasoconstriction type of headache.
Topics: Headache; Humans; Niacin; Nicotinic Acids; Vasoconstriction | 1953 |
A newer method of nicotinic acid therapy in headache of the vasoconstrictive type.
Topics: Headache; Humans; Niacin; Nicotinic Acids | 1955 |
[Treatment of therapy-resisting headaches with a mixture of causat and high percentage dextrose].
Topics: Atropine; Glucose; Headache; Humans; Niacin; Nicotinic Acids; Phenobarbital; Procaine | 1957 |
The treatment of premenstrual headache.
Topics: Female; Headache; Humans; Isomerism; Niacin; Nicotinic Acids; Premenstrual Syndrome | 1959 |
[HEADACHES].
Topics: Amyl Nitrite; Carotid Artery Diseases; Classification; Ephedrine; Epinephrine; Ergotamine; Headache; | 1963 |
MODERN CONCEPTS OF THE MANAGEMENT OF HISTAMINIC CEPHALALGIA.
Topics: Atropa belladonna; Caffeine; Ergotamine; Headache; Histamine; Humans; Methysergide; Muscarinic Antag | 1963 |
[FURTHER RESULTS IN THE TREATMENT OF THERAPY-RESISTANT HEADACHE].
Topics: Atropine; Glucose; Headache; Niacin; Nicotinic Acids; Phenobarbital; Procaine | 1964 |
Clinical study of headache relief with a niacin-containing compound.
Topics: Biomedical Research; Headache; Humans; Niacin; Nicotinic Acids | 1962 |
Treatment of tension headache.
Topics: Headache; Humans; Niacin; Nicotinic Acids; Tension-Type Headache | 1951 |